<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-A7MXJQ2E</identifier><date>2015</date><creator>Balaban, Milan</creator><creator>Jagodic Vilfan, Alenka Helena</creator><creator>Pavšar, Helena</creator><creator>Pisk, Nina</creator><relation>documents/doc/A/URN_NBN_SI_doc-A7MXJQ2E_001.pdf</relation><relation>documents/doc/A/URN_NBN_SI_doc-A7MXJQ2E_001.txt</relation><format format_type="issue">4</format><format format_type="volume">66</format><format format_type="type">article</format><format format_type="extent">str. 334-344</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">282485760</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-A7MXJQ2E</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">antikoagulacijska zdravila</subject><subject language_type_id="eng">drug</subject><subject language_type_id="slv">lekarništvo</subject><subject language_type_id="slv">neželeni učinki</subject><subject language_type_id="slv">zdravila</subject><title>Adverse drug reactions</title><title>Neželeni učinki zdravil</title><title>the role of community pharmacist in the case of novel oral anticoagulant drugs</title><title>vloga lekarniškega farmacevta na primeru novejših peroralnih antikoagulacijskih zdravil</title></Record>